title: [Advantages and drawbacks of in vitro Interferon-gamma/T cell assays compared to the Mantoux test for the diagnosis of tuberculosis].
abstract: The development of in vitro blood tests that measure the delayed hypersensitivity reaction developed after contact with Mycobacterium tuberculosis will change progressively the diagnosis of M. tuberculosis infection. These blood assays (Quantiferon TB Gold, Cellestis, Australia; T-SPOT.TB, Oxford Immunotec, United Kingdom) use specific, complex M. tuberculosis antigens (ESAT-6 and CFP-10), whereas the intra-dermal Mantoux test is done with tuberculin, a complex mixture of more than 200 antigens. ESAT-6 and CFP-10 are absent from all the BCG vaccine strains used throughout the world. Significant improvement in the specificity with equivalent or increased sensitivity of the in vitro tests compared to the Mantoux test will lead eventually to replacement of the latter.
authors.affiliation: Service de microbiologie, hôpital Saint-Louis, Paris, France. jean-louis.herrmann@rpc.aphp.fr
authors.forename: J-L
authors.initials: JL
authors.lastname: Herrmann
authors.forename: N
authors.initials: N
authors.lastname: Simonney
authors.forename: P-H
authors.initials: PH
authors.lastname: Lagrange
mesh_terms: D003937:Diagnosis, Differential; D006801:Humans; D006968:Hypersensitivity, Delayed; D007371:Interferon-gamma / Q000097:blood*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013601:T-Lymphocytes / Q000276:immunology*; D014373:Tuberculin; D014374:Tuberculin Test; D014376:Tuberculosis / Q000175:diagnosis* / Q000276:immunology
chemical_list: D014373:Tuberculin; D007371:Interferon-gamma